Allarity Therapeutics, Inc (ALLR) insider trading
Every open-market stock purchase and sale by Allarity Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- No open-market insider buys on record.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).
Recent ALLR insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jan 28, 2026 | Jeremy R. Graff (Officer) | Bought (not open market) | — |
| Jan 28, 2026 | Jeffrey S Ervin (CFO) | Bought (not open market) | — |
| Jan 28, 2026 | Gerald W. McLaughlin (Director) | Bought (not open market) | — |
| Jan 28, 2026 | Thomas Jensen (CEO) | Bought (not open market) | — |
| Jan 7, 2026 | Jeremy R. Graff (Officer) | Bought (not open market) | — |
| Jan 7, 2026 | Jesper Hoeiland (Director) | Bought (not open market) | — |
Who's trading ALLR
- Thomas Jensen, CEO: other filings, last Jan 28, 2026
- Gerald W. McLaughlin, Director: other filings, last Jan 28, 2026
- Jeffrey S Ervin, CFO: other filings, last Jan 28, 2026
- Jeremy R. Graff, Officer: other filings, last Jan 28, 2026
- Jesper Hoeiland, Director: other filings, last Jan 7, 2026
Get free alerts when an insider at Allarity Therapeutics, Inc files a new trade →